UK markets closed

Infinity Pharmaceuticals, Inc. (I3F.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.01710.0000 (0.00%)
At close: 08:36AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-40,948
-44,369
-45,262
-40,492
-47,057
Depreciation & amortisation
428
458
480
483
219
Stock-based compensation
4,569
3,621
2,695
1,456
2,133
Change in working capital
-1,558
-1,039
2,214
1,385
1,383
Accounts payable
-2,371
-300
2,177
882
1,550
Other working capital
-38,884
-42,448
-40,629
-35,782
-43,857
Other non-cash items
-1,375
-1,102
-745
1,429
1,792
Net cash provided by operating activities
-38,884
-42,431
-40,618
-35,739
-41,530
Cash flows from investing activities
Investments in property, plant and equipment
-
-17
-11
-43
-2,327
Purchases of investments
-19
-16,038
0
-43,006
-41,864
Sales/maturities of investments
10,750
16,000
5,500
57,680
31,950
Net cash used for investing activities
10,731
-55
5,489
14,631
-12,241
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
61
73
87,105
7,869
112
Other financing activities
-
-
-
19,572
27,618
Net cash used provided by (used for) financing activities
61
73
87,105
27,441
27,730
Net change in cash
-28,092
-42,413
51,976
6,333
-26,041
Cash at beginning of period
45,996
80,884
28,908
22,575
48,616
Cash at end of period
17,904
38,471
80,884
28,908
22,575
Free cash flow
Operating cash flow
-38,884
-42,431
-40,618
-35,739
-41,530
Capital expenditure
-
-17
-11
-43
-2,327
Free cash flow
-38,884
-42,448
-40,629
-35,782
-43,857